ClinConnect ClinConnect Logo
Search / Trial NCT05963308

Promoting Sustainable Return to Work Among Employees on Sick Leave Due to a Mental Health Condition: Evaluation of the HealthyMinds Online Group Intervention

Launched by UNIVERSITÉ DU QUÉBEC A MONTRÉAL · Jul 18, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying an online program called Healthy Minds, designed to help people with mood disorders like depression or anxiety successfully return to work after taking time off. The goal is to see if participating in this online group intervention makes it easier for individuals to go back to work and stay there compared to those who don’t participate. The researchers will look at various factors over a year, including how participants feel emotionally and how well they function at work.

To take part in this study, you need to be planning to return to work soon after being on sick leave for mental health reasons, or you should have just gone back to work within the last month. Participants will fill out online questionnaires at different times to track their progress. Those in the program will join an 8-week online group where they’ll learn helpful tools and strategies for returning to work. It’s important to note that participants must be comfortable communicating in French and should not have received similar therapy before. This trial aims to provide valuable insights on supporting individuals facing these challenges in the workplace.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be in the process of returning to work after depression, anxiety disorder, adjustment disorder (with depressed mood, or anxious mood).
  • or
  • Been back for less than a month
  • Exclusion Criteria:
  • Inability to communicate in French
  • Have a known organic disorder
  • Have already received CBT-type intervention (group or individual)

About Université Du Québec A Montréal

Université du Québec à Montréal (UQAM) is a leading public research university located in Montreal, Canada, renowned for its commitment to academic excellence and innovation. As a clinical trial sponsor, UQAM leverages its interdisciplinary expertise and state-of-the-art facilities to advance medical research and improve health outcomes. The university fosters collaboration among researchers, healthcare professionals, and industry partners to conduct rigorous clinical studies that address pressing health challenges. With a strong focus on ethical practices and adherence to regulatory standards, UQAM is dedicated to contributing valuable insights to the field of medicine and enhancing patient care through evidence-based research.

Locations

Montréal, Quebec, Canada

Patients applied

0 patients applied

Trial Officials

Marc Corbière, PhD

Principal Investigator

Université du Québec a Montréal

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported